Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia
Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia have?
Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia has 149 citations in the OpenAlex counts ScholarIQ stores.
When was Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia published?
Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia has 2011 year in the ScholarIQ index.
What is the open-access status of Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia?
Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia has gold oa status in the ScholarIQ index.
What is the DOI of Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia?
The DOI for Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia is on the source record.
What is the PMID of Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia?
The PMID for Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia is on the source record.
What is the OpenAlex record for Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia?
The OpenAlex for Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia is on the source record.